232 related articles for article (PubMed ID: 32027758)
1. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
[TBL] [Abstract][Full Text] [Related]
2. Going Viral: An Investigation into the Chameleonic Behaviour of Antiviral Compounds.
Wieske LHE; Atilaw Y; Poongavanam V; Erdélyi M; Kihlberg J
Chemistry; 2023 Feb; 29(8):e202202798. PubMed ID: 36286339
[TBL] [Abstract][Full Text] [Related]
3. Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design.
Ramelot TA; Palmer J; Montelione GT; Bhardwaj G
Curr Opin Struct Biol; 2023 Jun; 80():102603. PubMed ID: 37178478
[TBL] [Abstract][Full Text] [Related]
4. Controlling the Chameleonic Behavior and Membrane Permeability of Cyclosporine Derivatives via Backbone and Side Chain Modifications.
Lee D; Choi J; Yang MJ; Park CJ; Seo J
J Med Chem; 2023 Sep; 66(18):13189-13204. PubMed ID: 37718494
[TBL] [Abstract][Full Text] [Related]
5. Managing Experimental 3D Structures in the Beyond-Rule-of-5 Chemical Space: The Case of Rifampicin.
Ermondi G; Lavore F; Vallaro M; Tiana G; Vasile F; Caron G
Chemistry; 2021 Jul; 27(40):10394-10404. PubMed ID: 34114271
[TBL] [Abstract][Full Text] [Related]
6. Cell permeability beyond the rule of 5.
Matsson P; Doak BC; Over B; Kihlberg J
Adv Drug Deliv Rev; 2016 Jun; 101():42-61. PubMed ID: 27067608
[TBL] [Abstract][Full Text] [Related]
7. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5.
Rossi Sebastiano M; Doak BC; Backlund M; Poongavanam V; Over B; Ermondi G; Caron G; Matsson P; Kihlberg J
J Med Chem; 2018 May; 61(9):4189-4202. PubMed ID: 29608068
[TBL] [Abstract][Full Text] [Related]
8. Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader.
Ermondi G; Jimenez DG; Rossi Sebastiano M; Kihlberg J; Caron G
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678900
[TBL] [Abstract][Full Text] [Related]
9. Molecular chameleons in drug discovery.
Poongavanam V; Wieske LHE; Peintner S; Erdélyi M; Kihlberg J
Nat Rev Chem; 2024 Jan; 8(1):45-60. PubMed ID: 38123688
[TBL] [Abstract][Full Text] [Related]
10. Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
Poongavanam V; Danelius E; Peintner S; Alcaraz L; Caron G; Cummings MD; Wlodek S; Erdelyi M; Hawkins PCD; Ermondi G; Kihlberg J
ACS Omega; 2018 Sep; 3(9):11742-11757. PubMed ID: 30320271
[TBL] [Abstract][Full Text] [Related]
11. Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs.
Garcia Jimenez D; Vallaro M; Rossi Sebastiano M; Apprato G; D'Agostini G; Rossetti P; Ermondi G; Caron G
J Med Chem; 2023 Aug; 66(15):10681-10693. PubMed ID: 37490408
[TBL] [Abstract][Full Text] [Related]
12. Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure.
Fouché M; Schäfer M; Berghausen J; Desrayaud S; Blatter M; Piéchon P; Dix I; Martin Garcia A; Roth HJ
ChemMedChem; 2016 May; 11(10):1048-59. PubMed ID: 27154275
[TBL] [Abstract][Full Text] [Related]
13. Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.
Schwochert J; Lao Y; Pye CR; Naylor MR; Desai PV; Gonzalez Valcarcel IC; Barrett JA; Sawada G; Blanco MJ; Lokey RS
ACS Med Chem Lett; 2016 Aug; 7(8):757-61. PubMed ID: 27563399
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and guidelines for discovery of orally absorbed drugs in beyond rule of 5 space.
Poongavanam V; Doak BC; Kihlberg J
Curr Opin Chem Biol; 2018 Jun; 44():23-29. PubMed ID: 29803972
[TBL] [Abstract][Full Text] [Related]
15. Design Principles for Intestinal Permeability of Cyclic Peptides.
Mathiowetz AM
Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs.
Whitty A; Zhong M; Viarengo L; Beglov D; Hall DR; Vajda S
Drug Discov Today; 2016 May; 21(5):712-7. PubMed ID: 26891978
[TBL] [Abstract][Full Text] [Related]
17. Beyond Rule-of-five: Permeability Assessment of Semipeptidic Macrocycles.
L'Exact M; Comeau C; Bourhis A; Boisvert O; Fröhlich U; Létourneau D; Marsault É; Lavigne P; Grandbois M; Boudreault PL
Biochim Biophys Acta Biomembr; 2023 Oct; 1865(7):184196. PubMed ID: 37400050
[TBL] [Abstract][Full Text] [Related]
18. Addressing Challenges of Macrocyclic Conformational Sampling in Polar and Apolar Solvents: Lessons for Chameleonicity.
Tang X; Kokot J; Waibl F; Fernández-Quintero ML; Kamenik AS; Liedl KR
J Chem Inf Model; 2023 Nov; 63(22):7107-7123. PubMed ID: 37943023
[TBL] [Abstract][Full Text] [Related]
19. Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides.
Nielsen DS; Lohman RJ; Hoang HN; Hill TA; Jones A; Lucke AJ; Fairlie DP
Chembiochem; 2015 Nov; 16(16):2289-93. PubMed ID: 26336864
[TBL] [Abstract][Full Text] [Related]
20. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.
Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G
Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
